Comparative safety of long-acting inhaled bronchodilators: a cohort study using the UK THIN primary care database.
作者： Michele Jara , Stephan F Lanes , Charles Wentworth , Corey May , Steven Kesten
DOI: 10.2165/00002018-200730120-00007
关键词:
摘要: Background: Use of a long-acting inhaled bronchodilator, either an anticholinergic or β-adrenergic receptor agonist (β-agonist), is recommended for maintenance treatment chronic obstructive pulmonary disease (COPD). In COPD, the organ system most frequently requiring medical care, other than respiratory system, cardiac system.
springer.com
sci-hub.se 参考文章(31)
Graeme P Currie, Daniel K C Lee, Brian J Lipworth, Pharmacological management—oral treatment BMJ. ,vol. 332, pp. 1497- 1499 ,(2006) , 10.1136/BMJ.332.7556.1497
Jacobo Mintzer, Alistair Burns, Anticholinergic side-effects of drugs in elderly people. Journal of the Royal Society of Medicine. ,vol. 93, pp. 457- 462 ,(2000) , 10.1177/014107680009300903
François Maltais, Alan Hamilton, Darcy Marciniuk, Paul Hernandez, Frank C. Sciurba, Kai Richter, Steven Kesten, Denis O’Donnell, Improvements in Symptom-Limited Exercise Performance Over 8 h With Once-Daily Tiotropium in Patients With COPD Chest. ,vol. 128, pp. 1168- 1178 ,(2005) , 10.1378/CHEST.128.3.1168
Milind P Sovani, Christopher I Whale, Anne E Tattersfield, A Benefit-Risk Assessment of Inhaled Long-Acting β2-Agonists in the Management of Obstructive Pulmonary Disease Drug Safety. ,vol. 27, pp. 689- 715 ,(2004) , 10.2165/00002018-200427100-00001
James D. Lewis, Rita Schinnar, Warren B. Bilker, Xingmei Wang, Brian L. Strom, Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research Pharmacoepidemiology and Drug Safety. ,vol. 16, pp. 393- 401 ,(2007) , 10.1002/PDS.1335
V Brusasco, R Hodder, M Miravitlles, L Korducki, L Towse, S Kesten, Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD Thorax. ,vol. 61, pp. 91- 91 ,(2003) , 10.1136/THX.2005.BRUSASCOLETT
Peter J. Barnes, Chronic obstructive pulmonary disease ,(1980)
Mario Cazzola, Francesco Imperatore, Antonello Salzillo, Felice Di Perna, Francesco Calderaro, Aldo Imperatore, Maria Gabriella Matera, Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia Chest. ,vol. 114, pp. 411- 415 ,(1998) , 10.1378/CHEST.114.2.411
Leonard E. Braitman, Paul R. Rosenbaum, Rare outcomes, common treatments: analytic strategies using propensity scores. Annals of Internal Medicine. ,vol. 137, pp. 693- 695 ,(2002) , 10.7326/0003-4819-137-8-200210150-00015
F. Maltais, A. Hamilton, D. Marciniuk, P. Hernandez, F.C. Sciurba, K. Richter, S. Kesten, D. O’Donnell, Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD: Chest 2005;128:1168–78 Respiratory Medicine: Copd Update. ,vol. 1, pp. 146- ,(2006) , 10.1016/J.RMEDU.2006.03.038